2022
DOI: 10.1007/978-3-031-14615-2_45
|View full text |Cite
|
Sign up to set email alerts
|

Data Visualization for Industry 4.0: Developing Dashboards with Power BI – A Case Study in a Pharmaceutical Company

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Data storage can rely on traditional solutions such as relational databases or more advanced ones such as cloud databases. Data visualization and processing can be handled, instead, through Business Intelligence (BI) software (Microsoft PowerBI), allowing the management of large amounts of data and the creation of graphical interfaces for easy reference by all stakeholders [35].…”
Section: Discussionmentioning
confidence: 99%
“…Data storage can rely on traditional solutions such as relational databases or more advanced ones such as cloud databases. Data visualization and processing can be handled, instead, through Business Intelligence (BI) software (Microsoft PowerBI), allowing the management of large amounts of data and the creation of graphical interfaces for easy reference by all stakeholders [35].…”
Section: Discussionmentioning
confidence: 99%
“…Several works were presented in the literature in order to design, create and implement dashboards in different fields, such as Production [8]. For more information on dashboard visualization and user his properties, interested readers can refer to the full review suggested by [9].…”
Section: Introductionmentioning
confidence: 99%
“…Though some work has been done in the literature on the implementation of dashboards in the pharmaceutical sector to propose key indicators and develop dashboards in the pharmaceutical sector [3,4,8,10]. Particularly, we can cite papers focusing on studying sales performance and predictions in pharmaceutical companies as [11,12].…”
Section: Introductionmentioning
confidence: 99%